GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,186,000 | +59.9% | 252,420 | +57.2% | 4.47% | +18.5% |
| Q1 2022 | $6,994,000 | +39.3% | 160,568 | +41.0% | 3.77% | +0.7% |
| Q4 2021 | $5,021,000 | +40.6% | 113,866 | +21.8% | 3.75% | +14.5% |
| Q3 2021 | $3,572,000 | +2.3% | 93,485 | +6.6% | 3.27% | +0.2% |
| Q2 2021 | $3,492,000 | +18.2% | 87,686 | +5.9% | 3.27% | +6.4% |
| Q1 2021 | $2,955,000 | -63.1% | 82,792 | -62.0% | 3.07% | -2.1% |
| Q4 2020 | $8,016,000 | +20.9% | 217,817 | +23.6% | 3.14% | -2.2% |
| Q3 2020 | $6,632,000 | +26.4% | 176,186 | +36.9% | 3.21% | +18.5% |
| Q2 2020 | $5,248,000 | +8.1% | 128,664 | +0.4% | 2.71% | -13.3% |
| Q1 2020 | $4,854,000 | -19.7% | 128,112 | -0.5% | 3.13% | +13.0% |
| Q4 2019 | $6,047,000 | +9.5% | 128,695 | -0.5% | 2.77% | +3.9% |
| Q3 2019 | $5,521,000 | +7.0% | 129,352 | +0.3% | 2.66% | +7.0% |
| Q2 2019 | $5,159,000 | – | 128,907 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |